Langsam Jeffrey bought TOI

March 27, 2026 · Form 4 insider transaction

Langsam Jeffrey bought 70,270 shares of Starling Oncology Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Acquired (buy-side)
Shares
70,270
Price
$0.00
Total value
N/A
Role
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 27, 2026
Filing dateApril 1, 2026
Shares owned after127,650
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

View the original Form 4 on SEC EDGAR